J Korean Neuropsychiatr Assoc.  2001 Jan;40(1):151-156.

Hyperglycemia Associated with Mirtazapine: A Case Report

Affiliations
  • 1Department of Neuropsychiatry, Maryknoll Hospital, Pusan.

Abstract

Mirtazapine-a newly developed drug with reduce adverse effects and toxicity of original antidepre-ssants-has been known to have antidepressant effect by enhancing the transmission of norepinephrine and serotonin via blockade of alpha2-noradrenergic autoreceptor and heteroreceptor and to have common side effects such as sedation, weight gain, and dizziness. We report a case of 50 years old female depressive patient who developed mirtazapine-associated hyperglycemia during treatment with mirtazapine and returned to normal glucose level after stopping the usage of mirtazapine. In patients who receive drugs with the risk of hyperglycemia and diabetes mellitus, we should consider the evaluation for diabetes mellitus and follow it up carefully in the future.

Keyword

Mirtazapine; Hyperglycemia; Diabetes mellitus

MeSH Terms

Autoreceptors
Diabetes Mellitus
Dizziness
Female
Glucose
Humans
Hyperglycemia*
Middle Aged
Norepinephrine
Serotonin
Weight Gain
Autoreceptors
Glucose
Norepinephrine
Serotonin
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr